The phase 3 trial AMPLIFY study plans to test the diagnostic performance of 64Cu-SAR-bisPSMA PET/CT imaging in approximately ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

In this feature we spoke to Michael J. Morris, MD, and Benjamin Garmezy, MD, on the future of radioligand therapy in patients ...

Siemens Healthineers, India’s recent partnership with HealthCare Global Enterprises (HCG), is aimed to revolutionize cancer ...

Clarity Pharmaceuticals Dr Alan Taylor    Catherine Strong Executive Chairman   Investor/Media Relations ataylor@claritypharm.

In an exclusive interview, Tiger King star Joe Exotic revealed details about his ailing prison nightmare and new cancer ...

The "Radiology Market by Modality (Computed Tomography, Fluoroscopy, Magnetic Resonance Imaging), Application (Cardiology, ...

(UroToday.com) The 2024 American Urological Association (AUA) Annual Meeting held in San Antonio, TX between May 3 rd and 6 th, 2024 was host to an advanced prostate cancer moderated poster session.

Bayer seeks European approval for darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, October 16, 2024, 13:00 Hrs [IST] ...

Breast cancer is a disease where cells in the breast grow uncontrollably, forming a tumour. It usually starts in the milk ...

According to The Insight Partners study on the Radiation Oncology Market is observing significant growth owing to the ...

The researchers used the CellSearch assay to measure circulating tumor cells and determine the response to certain treatments as well as survival outcomes.